01 April,2024 06:50 PM IST | Mumbai | IANS
Image for representational purposes only. Photo Courtesy: iStock
Researchers at King George's Medical University (KGMU) in Lucknow Uttar Pradesh (UP) have identified a blood marker called TNFα (tumour necrosis factor-alpha) that can aid in the earlier detection and treatment of various health conditions, including chronic gum disease (periodontitis), obstructive sleep apnoea (OSA) and heart disease.
The study, titled âTo evaluate the relationship of obstructive sleep apnoea with chronic periodontitis and its association with coronary artery disease by assessing serum tumour necrosis factor', was recently published in the âThe Egyptian Journal of Internal Medicine'.
The researchers, led by MDS student Dr Shilpi Gupta at the Department of Periodontology, emphasised the significance of TNFα as a crucial blood marker for the early detection and treatment of these health conditions.
Also Read: Health cover denial sparks mother's advocacy for autistic son
ALSO READ
Exposure to air pollution may harm male and female fertility: Doctor
Trump names Kolkata-born doctor-researcher to head NIH research powerhouse
Is there a link between depression and menstrual pain? Study finds out
Four expert-backed tips to prevent joint pain during winters
Railways CPR video: Cardiologist shares dos and don’ts of life-saving procedure
Dr Gupta explained: "By utilising TNFα, we can potentially enhance the treatment and management of these diseases, as there hasn't been a reliable marker for them previously. For instance, we analysed periodontal pocket depth for periodontitis and conducted angiography for heart disease."
She said that they had examined 300 individuals with gum disease, sleep issues (OSA) and heart disease, comparing them to 300 healthy counterparts.
Blood samples were collected from each participant and analysed for TNFα levels using specialised PCR kits.
They discovered significantly higher TNFα levels in the affected group, averaging at 54 compared to 38 in the healthy group. This suggests elevated TNFα levels in individuals suffering from all three conditions.
Dr Gupta said, "Findings also suggest a potential link between chronic periodontitis and CHD, as indicated by differences in TNFα levels."
Prof Umesh Pratap Verma, who supervised the research, emphasised, "Traditionally, dentists have lacked reliable tools to track gum disease progression. This research underscores the potential of TNFα as a biomarker for early detection of not only gum disease but also sleep apnoea and predicting heart disease severity."
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
